SCHEMBL30494171

SCHEMBL30494171

CSC1=N/C(=C\c2ccc3c(cnn3C)c2)C(=O)N1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.57
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ CBS P35520 1/20 0.56
▸ DYRK1A Q13627 8/20 0.44
▸ DYRK1B Q9Y463 8/20 0.44
▸ DYRK2 Q92630 8/20 0.44
▸ DYRK3 O43781 6/20 0.44
▸ PIM1 P11309 2/20 0.44
▸ CLK1 P49759 7/20 0.41
▸ CLK4 Q9HAZ1 6/20 0.41
▸ CLK2 P49760 4/20 0.41
▸ CLK3 P49761 3/20 0.41
▸ DYRK4 Q9NR20 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26091714 1.00 MAPT (0.57) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26104192 0.79 MAPT (0.59) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30494268 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26093748 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26095879 0.78 MAPT (0.56) MAPTDYRK1ADYRK1BDYRK2DYRK3
SCHEMBL30363334 0.77 MAPT (0.55) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26103947 0.77 MAPT (0.55) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26093284 0.76 MAPT (0.57) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30363432 0.75 MAPT (0.60) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26106872 0.75 MAPT (0.60) MAPTCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback